Loading...
Thumbnail Image
Item

COVID-19 Vaccine Trial Begins At UMB

Authors
Morrison, Joanne
Advisor
Date
2020-08-13
Embargo until
Language
Book title
Publisher
Peer Reviewed
Type
Article
Video
Research Area
Jurisdiction
Other Titles
Abstract
Data Availibility
Data / Code Location
Table of Contents
Description
Researchers at the University of Maryland School of Medicine (UMSOM) have begun participation in the Phase 3 clinical trial of an investigational COVID-19 vaccine co-developed by scientists at Moderna Inc. and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Video includes brief interview with UMB President, Bruce E. Jarrell, MD, FACS, who is a participant in the trial.
Citations
Altmetric:
Series/Report No.
Sponsors
Rights/Terms
Citation
Identifier to cite or link to this item
Scopus Identifier
Embedded videos